Rachel joined KalVista in 2016. She has more than 25 years of regulatory and QA leadership experience. In her role as Senior Vice President at KalVista, she is responsible for global Regulatory and QA activities. Prior to joining KalVista, Rachel was the founder of Q-Regulatory Ltd., a regulatory and quality assurance consultancy. She began her career at Glaxo and, after 10 years in regulatory affairs, founded ChapelPharma Ltd., a regulatory, clinical and QA consulting company which was eventually acquired by Hesperion (now part of ICON). From 2009-2011, Rachel was Head, Regulatory Affairs and QA at Vantia Ltd.
Rachel received a BSc (Hons) in Microbiology from Chelsea College, University of London. She was elected a Fellow of The Organisation for Professionals in Regulatory Affairs (TOPRA) in 2012.
